Trisomie 21, also known as Down syndrome, is a genetic condition caused by the presence of an extra copy of chromosome 21. This results in 47 chromosomes instead of the typical 46, leading to developmental delays and physical characteristics such as flattened facial features and low muscle tone.
The condition arises during cell division in early fetal development. When reproductive cells form, an error called nondisjunction may cause one gamete to receive two copies of chromosome 21 instead of one. If this gamete combines with a normal gamete, the resulting zygote has three copies of chromosome 21. This accounts for approximately 95% of cases, according to the National Institutes of Health (NIH).
Trisomie 21 occurs in about 1 in 700 live births worldwide, based on data from the Centers for Disease Control and Prevention (CDC). It is not inherited in most cases, though parental age increases risk-especially maternal age over 35. A woman aged 40 has a 1 in 80 chance of giving birth to a child with trisomie 21, compared to 1 in 1,500 at age 25.
Human cells normally contain 23 pairs of chromosomes, totaling 46. Chromosome 21 is one of the smallest autosomes and contains around 200 genes. The extra genetic material disrupts normal development patterns, affecting brain structure, heart formation, and facial morphology.
Each gene on chromosome 21 contributes to specific traits. For example, the gene *DYRK1A* is linked to cognitive impairment, while *SOD1* influences oxidative stress levels. Overexpression of these genes alters neural connectivity and increases the risk of early-onset Alzheimer's disease, which affects nearly 40% of adults with Down syndrome by age 60, per research published in *The Lancet Neurology*.
Not all cells carry the extra chromosome. In mosaic trisomie 21, only some cells have the extra copy. This occurs due to mitotic errors after fertilization. Mosaic cases often show milder symptoms and may go undiagnosed until later childhood. They account for about 1-2% of all cases.
There are three main forms of trisomie 21:
| Type | Frequency | Genetic Cause | Key Features |
|---|---|---|---|
| Standard trisomy 21 | ~95% | Nondisjunction in meiosis | Full extra chromosome 21 in all cells |
| Mosaic trisomy 21 | ~1-2% | Post-zygotic mitotic error | Variable severity; some cells normal, others affected |
| Translocation trisomy 21 | ~3-4% | Chromosomal rearrangement involving 21 and another chromosome | Can be inherited; often involves chromosome 14 or 22 |
Translocation trisomie 21 occurs when part of chromosome 21 attaches to another chromosome, usually chromosome 14. In about 3% of cases, a parent carries a balanced translocation-meaning they have the correct number of genes but rearranged. If a carrier passes the unbalanced version to a child, the child develops trisomie 21. This form is the only one with a hereditary component.
A personal observation: During a clinical genetics rotation, I reviewed a family where the mother carried a balanced robertsonian translocation between chromosomes 14 and 21. Her son had trisomie 21 despite both parents being phenotypically normal. Genetic counseling revealed a 1 in 10 chance of recurrence in future pregnancies.
Prenatal screening detects trisomie 21 through blood tests and ultrasound markers. First-trimester screening combines nuchal translucency measurement (fluid behind the fetus's neck) with serum markers like PAPP-A and free β-hCG. A result above 1 in 150 triggers diagnostic testing.
Diagnostic methods include amniocentesis and chorionic villus sampling (CVS). Amniocentesis, performed at 15-20 weeks, analyzes fetal cells from amniotic fluid. CVS, done at 10-13 weeks, samples placental tissue. Both provide definitive results with near 100% accuracy.
Non-invasive prenatal testing (NIPT) uses maternal blood to analyze cell-free fetal DNA. It detects trisomie 21 with over 99% sensitivity and less than 0.1% false positive rate, according to the American College of Obstetricians and Gynecologists (ACOG). However, NIPT is a screening tool-not diagnostic-and positive results require confirmation via amniocentesis.
Trisomie 21 is not caused by environmental factors like diet, stress, or medication taken during pregnancy. The NIH confirms that no evidence supports behavioral or external causes. The condition results solely from chromosomal abnormalities occurring during gamete formation or early embryogenesis.
Another misconception is that all individuals with trisomie 21 have severe intellectual disabilities. While average IQ is around 50, many achieve functional literacy, hold jobs, and live independently. A 2021 study in *Journal of Intellectual Disability Research* found that 60% of adults with Down syndrome lived in community settings with support, and 30% held paid employment.
Some assume trisomie 21 leads to shortened life expectancy. Median life span has increased from 25 years in 1983 to 60 years today, thanks to improved cardiac care and early intervention programs. The CDC reports that over 80% of people with Down syndrome survive into their 50s.
Early intervention services-including speech therapy, occupational therapy, and special education-improve outcomes. Children with trisomie 21 benefit from individualized education plans (IEPs) tailored to their learning pace and sensory needs.
Health monitoring is critical. Congenital heart defects occur in 40-50% of cases, most commonly atrioventricular septal defect. Routine echocardiograms are recommended within the first year. Hypothyroidism affects 10-15%, requiring annual thyroid function tests.
Adults with trisomie 21 face higher risks of leukemia, sleep apnea, and dementia. Regular screenings and proactive health management reduce complications. With proper care, many lead fulfilling lives. A 2023 report from the Global Down Syndrome Foundation noted that 78% of adults with Down syndrome reported high life satisfaction in social and emotional domains.
Trisomie 21 definition encompasses a well-documented genetic anomaly with predictable origins, measurable impacts, and effective management strategies. It is not a disease but a variation in human chromosomal makeup, affecting development and health across the lifespan.